JOHN TSAI

Novartis appoints John Tsai as Head of Global Drug Development and CMO

Novartis announced today the appointment of John Tsai, M.D. as Head of Global Drug Development (GDD) and Chief Medical Officer. Dr. Tsai will join Novartis on May 1, 2018, and will be based in Basel.